New Market Report: China Pharmaceuticals and Healthcare Report Q1 2014
Multinational pharmaceutical firms' commitment to the Chinese market is underpinned by the potential of the healthcare sector. The sector itself is supported by consistent government efforts, thereby increasing patients' access to these drugs. We would also highlight risks of operating in China, such as the anti-bribery investigation and volatility caused by tender timings. Headline Expenditure Projections
View full press release